Approval · Notice of Compliance 37150 · 2026

METADOL: Notice of Compliance 37150

Issued March 20, 2026

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 37150
Date: March 20, 2026
Company: Knight Therapeutics Inc.Montreal, Quebec, Canada
Product type: Prescription Pharmaceutical
Submission: New Drug Submission (NDS)
Submission class: Admin
Reason: Administrative: Change in product ownership

Products in this notice

Brand	DIN	Status today
METADOL	02247698	Marketed
METADOL	02247699	Marketed
METADOL	02247700	Marketed
METADOL	02247701	Marketed
METADOL	02247694	Marketed
METADOL	02241377	Marketed

Medicinal ingredients

METHADONE HYDROCHLORIDE 1 MG per TAB
METHADONE HYDROCHLORIDE 5 MG per TAB
METHADONE HYDROCHLORIDE 10 MG per TAB
METHADONE HYDROCHLORIDE 25 MG per TAB
METHADONE HYDROCHLORIDE 1 MG per ML
METHADONE HYDROCHLORIDE 10 MG per ML